Literature DB >> 10224361

Cloned Th cells confer eosinophilic inflammation and bronchial hyperresponsiveness.

O Kaminuma1, A Mori, K Ogawa, A Nakata, H Kikkawa, K Ikezawa, H Okudaira.   

Abstract

BACKGROUND: The essential role of Th cells and T cell cytokines in eosinophilic inflammation has been established.
METHODS: To determine whether Th cells are sufficient for the development of airway eosinophilic inflammation, ovalbumin-reactive murine Th clones were established and infused into unprimed mice.
RESULTS: Eosinophilic infiltration into the lung was induced upon antigen inhalation in parallel with the rise in bronchoalveolar lavage fluid (BALF) eosinophil peroxidase activity. Neither IgG, IgA, nor IgE antibodies were present in this model. Pathological examination showed swelling and desquamation of epithelial cells, mucous plugs, and goblet cell hyperplasia, all of which well resemble human asthma. Fluorescent probe labeled Th clones migrated into the lung prior to the eosinophil accumulation. Bronchial hyperresponsiveness (BHR) was clearly induced upon antigen inhalation. Anti-IL-5 monoclonal antibody abrogated the responses. Dexamethasone and cyclosporin A suppressed cytokine production by Th cells both in vitro and in vivo, BALF eosinophilia, and BHR. The number of eosinophils recovered in the BALF correlated with the intensity of BHR.
CONCLUSION: The results clearly indicated that monoclonal Th cells are sufficient for the development of both airway eosinophilia and BHR. Agents capable of downregulating IL-5 production seem promising for the treatment of bronchial asthma.

Entities:  

Mesh:

Year:  1999        PMID: 10224361     DOI: 10.1159/000024050

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  2 in total

1.  Proinflammatory cytokines (IL-17, IL-6, IL-18 and IL-12) and Th cytokines (IFN-gamma, IL-4, IL-10 and IL-13) in patients with allergic asthma.

Authors:  C K Wong; C Y Ho; F W Ko; C H Chan; A S Ho; D S Hui; C W Lam
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

Review 2.  Immune System Involvement in Specific Pain Conditions.

Authors:  Stacie K Totsch; Robert Ernest Sorge
Journal:  Mol Pain       Date:  2017 Jan-Dec       Impact factor: 3.395

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.